-
6-hydroxy-3,5,7,9,11,15,17-heptamethyl-19-(3-methyl-6-oxo-3,6-dihydro-2H-pyran-2-yl)-8-oxononadeca-2,10,12,16,18-pentaenoic acid
-
ChemBase ID:
154390
-
Molecular Formular:
C32H46O6
-
Molecular Mass:
526.70404
-
Monoisotopic Mass:
526.32943919
-
SMILES and InChIs
SMILES:
CC1C=CC(=O)OC1/C=C/C(=C/C(C)C/C=C/C(=C/C(C)C(=O)C(C)C(C(C)C/C(=C/C(=O)O)/C)O)/C)/C
Canonical SMILES:
C/C(=C\C(C(=O)C(C(C(C/C(=C/C(=O)O)/C)C)O)C)C)/C=C/CC(/C=C(/C=C/C1OC(=O)C=CC1C)\C)C
InChI:
InChI=1S/C32H46O6/c1-20(16-22(3)12-14-28-24(5)13-15-30(35)38-28)10-9-11-21(2)17-25(6)31(36)27(8)32(37)26(7)18-23(4)19-29(33)34/h9,11-17,19-20,24-28,32,37H,10,18H2,1-8H3,(H,33,34)
InChIKey:
QECBVZBMGUAZDL-UHFFFAOYSA-N
-
Cite this record
CBID:154390 http://www.chembase.cn/molecule-154390.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
6-hydroxy-3,5,7,9,11,15,17-heptamethyl-19-(3-methyl-6-oxo-3,6-dihydro-2H-pyran-2-yl)-8-oxononadeca-2,10,12,16,18-pentaenoic acid
|
|
|
IUPAC Traditional name
|
6-hydroxy-3,5,7,9,11,15,17-heptamethyl-19-(3-methyl-6-oxo-2,3-dihydropyran-2-yl)-8-oxononadeca-2,10,12,16,18-pentaenoic acid
|
|
|
Synonyms
|
19-(3,6-Dihydro-3-methyl-6-oxo-2H-pyran-2-yl)-3,5,7,9,11,15,17-heptamethyl-6-hydroxy-8-oxo-2,10,12,16,18-nonadecapentaenoic acid
|
Jildamycin
|
Leptomycin A
|
Leptomycin A 来源于链霉菌 属
|
|
|
CAS Number
|
|
MDL Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Polar Surface Area
|
100.9 Å2
|
Rotatable Bonds
|
14
|
Lipinski's Rule of Five
|
false
|
Acid pKa
|
4.568904
|
H Acceptors
|
5
|
H Donor
|
2
|
LogD (pH = 5.5)
|
6.1527057
|
LogD (pH = 7.4)
|
4.3783813
|
Log P
|
7.1308365
|
Molar Refractivity
|
157.877 cm3
|
Polarizability
|
59.455105 Å3
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
L6417
|
Biochem/physiol Actions Leptomycins are antifungal antibiotics with unique unsaturated, branched-chain fatty acid structures.1, The physiochemical and biological properties of Leptomycins A and B are very similar.2, Both are considered to be specific inhibitors of nuclear export. The suggested inhibition mechanism involves the direct binding of leptomycins to CRM1 (Exportin-1), which is the main nuclear export protein. This blocks the binding of CRM1 to proteins containing a nuclear export signal (NES),3,4 and therefore prevents their export from the nucleus. Although more research on nuclear export inhibition has been performed using Leptomycin B, it has been shown that Leptomycin A has similar effects and can induce, for example, nuclear accumulation of wild-type ERK5.5Leptomycin A is also active against Schizosaccaromyces pombe and Mucor rouxianus.2 |
PATENTS
PATENTS
PubChem Patent
Google Patent